FH-2001

N/A

Report date: 2024/11/15 09:07:56
NME

Base Information

Drug NameFH-2001
Drug Alias NameFH-2001
ClassificationSmall molecules
Mechanisms of ActionFibroblast growth factor receptors antagonistsProgrammed death-ligand 1 blockersVascular endothelial growth factor receptor antagonists
TargetsFibroblast growth factor receptorsProgrammed death-ligand 1Vascular endothelial growth factor receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Fosun Pharmaceutical Industrial Development Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Xingsheng Xinhui Pharmaceutical Co LtdShanghai Fosun Pharmaceutical Industrial Development Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A